Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients have?
Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients has 293 citations in the OpenAlex counts ScholarIQ stores.
When was Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients published?
Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients has 2008 year in the ScholarIQ index.
What is the open-access status of Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients?
Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients has closed oa status in the ScholarIQ index.
What is the DOI of Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients?
The DOI for Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients is on the source record.
What is the PMID of Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients?
The PMID for Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients is on the source record.
What is the OpenAlex record for Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients?
The OpenAlex for Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients is on the source record.